Engaging more directly with patients becomes critical for MedTech: to encourage early diagnosis, communicate therapy value, drive adoption, enable ongoing engagement and experience. Digital and omni-channel acceleration makes it easier than ever before. BlueJet Consulting can help MedTech define and implement patient engagement model. Read some great examples from Edwards Lifesciences, Zimmer Biomet or Hologic, Inc.. #gotomarketstrategy #bluejetconsulting #patientempowerment
Exciting discussions today during day 1 of European MedTech and Diagnostic Strategic Product Management conference by TT Group. Strong focus on driving innovation from product centric to customer centric solutions. #medtech #commercialexcellence #launchexcellence #bluejetconsulting Continue reading
Laurent Décory, BlueJet Consulting Managing Director, declared "I'm really proud to chair day 1 of European MedTech and Diagnostic Strategic Product Management conference by TT Group Worldwide, with fantastic industry speakers from companies like GE Healthcare, Invacare, Sonova or Wellspect". #BlueJet Consulting #medtech #commercialexcellence #launchexcellence Continue reading
BlueJet Consulting Managing Director Laurent Déory declared "I feel priviledged to chair day 1 of MedForce conference. Together with many senior speakers we aim to shape the future of MedTech: innovation, post-Covid acceleration, omni-channel transformation" #medtech #digitaltransformation #commercialexcellence Continue reading
Due to Covid-19 related procedure backlog, twice as many patients are willing to pay for cataract surgery, hip or knee replacement rather than waiting for months. Hard to say if the trend will stay, but Medtech companies should help hospitals identify and address the needs of this particular group of patients. #postcovid19 #medtech #commercialexcellence #bluejetconsulting Continue reading
Procedure volumes and hospital traffic continued to recover in August, as medtechs and investors regained confidence in increased demand for medical devices. #postcovid19 #medtech #bluejetconsulting Continue reading
Remote patient monitoring has dramatically increased with Covid-19 outbreak. For this to last, the technology must be easy to use by patients and clinicians, incorporated into clinician workflows, with sufficient non-physician staff dedicated to it. Few protocols meet all these conditions today. #postcovid19 #medtech #bluejetconsulting Continue reading
To reduce backlog of elective surgeries, hospitals such as Johns Hopkins are prioritizing procedures based on surgical risks, capacity requirements, and Covid-19 risks #postcovid19 #medtech #bluejetconsulting Continue reading
Planned $11.5 billion acquisition of QIAGEN by Thermo Fisher Scientific is terminated, as only 47.02% of Qiagen shares were tendered. The deal was largest in medtech this year, until Siemens Healthineers announcement to acquire radiation oncology Varian Medical Systems for $16.4 Bn. #mergersandacquisitions #duediligence #medtech Continue reading
How will Covid-19 outbreak impact Pharma and MedTech sales?
J&J forecast shared during the company’s first-quarter conference call give first clues: increased OTC sales, stable Rx, hardest impact on medical devices.
#covid19outbreak #pharma #medtech Continue reading
European Commission is preparing to delay Medical Device Regulation by one year.
Currently planned for 26 May 2020, MDR delay will be good new for most medtech, will relieve pressure and allow focus on coronavirus crisis.
#medtech #regulatoryrequirements #covid19